Theta-Burst Neuromodulation for PTSD

NCT ID: NCT02769312

Last Updated: 2019-03-26

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-01

Study Completion Date

2017-12-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the proposed study is to evaluate initial feasibility and efficacy of Theta Burst Transcranial Magnetic Stimulation (TBS) as an adjunct treatment for Veterans with PTSD. Primary outcomes measures include a feasibility of TBS procedures, with secondary outcome measures focusing on changes in PTSD symptom severity and quality of life and social/occupation functioning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the proposed study is to evaluate the feasibility of theta burst transcranial magnetic stimulation (TBS) as an adjunct treatment for Veterans with PTSD. This project will result in development of methods needed to conduct an adequately powered, randomized controlled study of TBS for PTSD, which will assess the relationship between change in symptoms and quality of life. It will also lay the foundation for subsequent rehabilitation studies combining neuromodulation and psychotherapy in the longer term.

TBS has several advantages compared to standard repetitive Transcranial Magnetic Stimulation (rTMS), including its ability to deliver large numbers of stimulation pulses in a shorter time period, and a stimulation pattern that may specifically affect key brain regions involved in PTSD. The significance of this research is the development of a novel, non-invasive brain stimulation approach for PTSD recovery. This project will provide the foundation for the development of methods needed to conduct an adequately powered, randomized controlled study of TBS for PTSD to ultimately develop brain stimulation techniques that can be combined with evidence-based psychotherapy, to develop a more powerful, individualized rehabilitation option for Veterans with PTSD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Post-Traumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sham Stimulation

A sham coil is being used to compare against active coil.

Group Type SHAM_COMPARATOR

Sham stimulation

Intervention Type DEVICE

Sham Theta burst transcranial magnetic stimulation

Active Stimulation

An active coil is being used to compare against sham coil.

Group Type ACTIVE_COMPARATOR

Theta burst stimulation

Intervention Type DEVICE

Theta burst transcranial magnetic stimulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Theta burst stimulation

Theta burst transcranial magnetic stimulation

Intervention Type DEVICE

Sham stimulation

Sham Theta burst transcranial magnetic stimulation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of chronic PTSD according to DSM-5 criteria
* Veteran (male or female)
* age between 18-70 years
* clinically symptomatic despite ongoing stable treatment regimens for at least 6 weeks prior to study procedures
* capable of independently reading and understanding patient information materials and providing informed consent

Exclusion Criteria

* Cardiac pacemaker
* implanted device (deep brain stimulation) or metal in the brain
* cervical spinal cord
* or upper thoracic spinal cord
* pregnancy/lactation, or planning to become pregnant during the study
* lifetime history of moderate or severe traumatic brain injury (TBI)
* current unstable medical conditions
* current (or past if appropriate) significant neurological disorder, or lifetime history of:

* seizure disorder
* primary or secondary CNS tumors
* stroke
* cerebral aneurysm
* primary psychotic disorder
* bipolar I disorder
* active moderate/severe substance use disorders (within the last month, excluding nicotine/caffeine
* active suicidal intent or plan
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Noah S. Philip, MD

Role: PRINCIPAL_INVESTIGATOR

Providence VA Medical Center, Providence, RI

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Providence VA Medical Center, Providence, RI

Providence, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Philip NS, Barredo J, Aiken E, Larson V, Jones RN, Shea MT, Greenberg BD, van 't Wout-Frank M. Theta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder. Am J Psychiatry. 2019 Nov 1;176(11):939-948. doi: 10.1176/appi.ajp.2019.18101160. Epub 2019 Jun 24.

Reference Type DERIVED
PMID: 31230462 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I21RX RX002032

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

D2032-P

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Focused Ultrasound for PTSD in Veterans
NCT06820138 NOT_YET_RECRUITING PHASE2
tDCS and Inhibitory Control in PTSD
NCT06100731 COMPLETED NA
Ultrasonic Neuromodulation for Treatment of PTSD
NCT06135064 TERMINATED PHASE1/PHASE2
3MDR to Treat PTSD With mTBI (3MDR)
NCT03796936 COMPLETED PHASE2